Viral targets of acylguanidines

Drug Discovery Today

Volumn 17, Issue 17-18, 2012, Pages 1039-1043

  Gazina, Elena V ^a   Petrou, Steven ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

5 (N,N HEXAMETHYLENE)AMILORIDE; ACYLGUANIDINE; ANTIVIRUS AGENT; BAFILOMYCIN A1; BENZAMIL; BIT 225; ION CHANNEL; PEGINTERFERON ALPHA; POTASSIUM SPARING DIURETIC AGENT; RIBAVIRIN; RNA POLYMERASE; SODIUM CHANNEL; UNCLASSIFIED DRUG; VIRUS PROTEIN; VPU PROTEIN;

ANTIVIRAL ACTIVITY; CANCER CELL; CELL DAMAGE; CELL LINE; CLINICAL TRIAL (TOPIC); CORONAVIRUS; COXSACKIE VIRUS B; CYSTIC FIBROSIS; FLAVIVIRUS; HEART INFARCTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; IN VIVO STUDY; LIVER CELL CARCINOMA; LIVER DISEASE; NONHUMAN; RECEPTOR DOWN REGULATION; REVIEW; SEVERE ACUTE RESPIRATORY SYNDROME; SYNTHESIS; VIRUS REPLICATION; XENOPUS;

ANIMALS; ANTIVIRAL AGENTS; GUANIDINES; HUMANS; VIRAL PROTEINS;

EID: 84865482669     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2012.05.002     Document Type: Review

References (60)

1. E.J. Cragoe Jr. Pyrazine diuretics. II. N-amidino-3-amino-5-substituted 6-halopyrazinecarboxamides J. Med. Chem. 10 1967 66 75
2. T.R. Kleyman, and E.J. Cragoe Jr. Amiloride and its analogs as tools in the study of ion transport J. Membr. Biol. 105 1988 1 21
3. B. Masereel An overview of inhibitors of Na(+)/H(+) exchanger Eur. J. Med. Chem. 38 2003 547 554
4. + exchanger isoform-1 J. Med. Chem. 48 2005 2882 2891 (Pubitemid 40552910)
5. P.H. Kilmarx Global epidemiology of HIV Curr. Opin. HIV AIDS 4 2009 240 246
6. E. Fanales-Belasio HIV virology and pathogenetic mechanisms of infection: a brief overview Ann. Ist. Super. Sanita 46 2010 5 14
7. A. Ruiz The Vpu protein: new concepts in virus release and CD4 down-modulation Curr. HIV Res. 8 2010 240 252
8. KU-lbMC33 in pig-tailed macaques Virology 313 2003 435 451 (Pubitemid 37040684)
9. K. Sato Vpu augments the initial burst phase of HIV-1 propagation and downregulates BST2 and CD4 in humanized mice J. Virol. 2012 10.1128/JVI.07062-11
10. G.D. Ewart The Vpu protein of human immunodeficiency virus type 1 forms cation-selective ion channels J. Virol. 70 1996 7108 7115 (Pubitemid 26307427)
11. U. Schubert Identification of an ion channel activity of the Vpu transmembrane domain and its involvement in the regulation of virus release from HIV-1-infected cells FEBS Lett. 398 1996 12 18 (Pubitemid 26400334)
12. G.D. Ewart Amiloride derivatives block ion channel activity and enhancement of virus-like particle budding caused by HIV-1 protein Vpu Eur. Biophys. J. 31 2002 26 35
13. G.D. Ewart Potential new anti-human immunodeficiency virus type 1 compounds depress virus replication in cultured human macrophages Antimicrob. Agents Chemother. 48 2004 2325 2330 (Pubitemid 38691643)
14. G. Khoury Antiviral efficacy of the novel compound BIT225 against HIV-1 release from human macrophages Antimicrob. Agents Chemother. 54 2010 835 845
15. U. Schubert The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains J. Virol. 70 1996 809 819 (Pubitemid 26028996)
16. S. Bolduan Ion channel activity of HIV-1 Vpu is dispensable for counteraction of CD317 Virology 416 2011 75 85
17. B.D. Kuhl The HIV-1 Vpu viroporin inhibitor BIT225 does not affect Vpu-mediated tetherin antagonism PLoS One 6 2011 E27660
18. A.H. Shah Degranulation of natural killer cells following interaction with HIV-1-infected cells is hindered by downmodulation of NTB-A by Vpu Cell Host Microbe 8 2010 397 409
19. M. Moll Inhibition of lipid antigen presentation in dendritic cells by HIV-1 Vpu interference with CD1d recycling from endosomal compartments Blood 116 2010 1876 1884
20. D. Lavanchy Evolving epidemiology of hepatitis C virus Clin. Microbiol. Infect. 17 2011 107 115
21. J. Vermehren, and C. Sarrazin New hepatitis C therapies in clinical development Eur. J. Med. Res. 16 2011 303 314
22. U.A. Ashfaq An overview of HCV molecular biology, replication and immune responses Virol. J. 8 2011 161
23. S. Carrere-Kremer Subcellular localization and topology of the p7 polypeptide of hepatitis C virus J. Virol. 76 2002 3720 3730 (Pubitemid 34250536)
24. D. Clarke Evidence for the formation of a heptameric ion channel complex by the hepatitis C virus p7 protein in vitro J. Biol. Chem. 281 2006 37057 37068 (Pubitemid 46042176)
25. S.D. Griffin The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, amantadine FEBS Lett. 535 2003 34 38 (Pubitemid 36126351)
26. D. Pavlovic The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives Proc. Natl. Acad. Sci. U.S.A. 100 2003 6104 6108 (Pubitemid 36576938)
27. A. Premkumar Cation-selective ion channels formed by p7 of hepatitis C virus are blocked by hexamethylene amiloride FEBS Lett. 557 2004 99 103 (Pubitemid 38115876)
28. C.T. Jones Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus J. Virol. 81 2007 8374 8383 (Pubitemid 47242811)
29. E. Steinmann Hepatitis C virus p7 protein is crucial for assembly and release of infectious virions PLoS Pathog. 3 2007 E103
30. A. Sakai The p7 polypeptide of hepatitis C virus is critical for infectivity and contains functionally important genotype-specific sequences Proc. Natl. Acad. Sci. U.S.A. 100 2003 11646 11651 (Pubitemid 37205990)
31. P. Gastaminza Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion J. Virol. 82 2008 2120 2129 (Pubitemid 351293514)
32. Y. Rouille Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virus J. Virol. 80 2006 2832 2841 (Pubitemid 43346378)
33. B. Boson A concerted action of hepatitis C virus p7 and nonstructural protein 2 regulates core localization at the endoplasmic reticulum and virus assembly PLoS Pathog. 7 2011 E1002144
34. P. Tedbury The subcellular localization of the hepatitis C virus non-structural protein NS2 is regulated by an ion channel-independent function of the p7 protein J. Gen. Virol. 92 2011 819 830
35. A.L. Wozniak Intracellular proton conductance of the hepatitis C virus p7 protein and its contribution to infectious virus production PLoS Pathog. 6 2010 E1001087
36. C.A. Luscombe A novel Hepatitis C virus p7 ion channel inhibitor, BIT225, inhibits bovine viral diarrhea virus in vitro and shows synergism with recombinant interferon-alpha-2b and nucleoside analogues Antiviral Res. 86 2010 144 153
37. M.G. Guzman Dengue: a continuing global threat Nat. Rev. Microbiol. 8 2010 S7 S16
38. S. Urcuqui-Inchima Recent developments in understanding dengue virus replication Adv. Virus Res. 77 2010 1 39
39. I.M. Yu Structure of the immature dengue virus at low pH primes proteolytic maturation Science 319 2008 1834 1837
40. A. Premkumar Dengue virus M protein C-terminal peptide (DVM-C) forms ion channels J. Membr. Biol. 204 2005 33 38 (Pubitemid 40966570)
41. S.S. Wong Dengue virus PrM/M proteins fail to show pH-dependent ion channel activity in Xenopus oocytes Virology 412 2011 83 90
42. S. Perlman, and J. Netland Coronaviruses post-SARS: update on replication and pathogenesis Nat. Rev. Microbiol. 7 2009 439 450
43. M.L. DeDiego A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo J. Virol. 81 2007 1701 1713
44. M.L. DeDiego Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic mice Virology 376 2008 379 389
45. J.L. Nieto-Torres Subcellular location and topology of severe acute respiratory syndrome coronavirus envelope protein Virology 415 2011 69 82
46. J. Torres Model of a putative pore: the pentameric alpha-helical bundle of SARS coronavirus E protein in lipid bilayers Biophys. J. 91 2006 938 947 (Pubitemid 44161926)
47. L. Wilson SARS coronavirus E protein forms cation-selective ion channels Virology 330 2004 322 331 (Pubitemid 39446589)
48. J. Torres Conductance and amantadine binding of a pore formed by a lysine-flanked transmembrane domain of SARS coronavirus envelope protein Protein Sci. 16 2007 2065 2071 (Pubitemid 47367129)
49. K. Pervushin Structure and inhibition of the SARS coronavirus envelope protein ion channel PLoS Pathog. 5 2009 E1000511
50. L. Wilson Hexamethylene amiloride blocks E protein ion channels and inhibits coronavirus replication Virology 353 2006 294 306 (Pubitemid 44397131)
51. L. Andreoletti Viral causes of human myocarditis Arch Cardiovasc. Dis. 102 2009 559 568
52. C.E. Cameron Expanding knowledge of P3 proteins in the poliovirus lifecycle Future Microbiol. 5 2010 867 881
53. C. Ferrer-Orta Structural insights into replication initiation and elongation processes by the FMDV RNA-dependent RNA polymerase Curr. Opin. Struct. Biol. 19 2009 752 758
54. B.P. Steil, and D.J. Barton Cis-active RNA elements (CREs) and picornavirus RNA replication Virus Res. 139 2009 240 252
55. D.N. Harrison Amiloride derivatives inhibit coxsackievirus B3 RNA replication J. Virol. 82 2008 1465 1473
56. E.V. Gazina Amiloride is a competitive inhibitor of coxsackievirus B3 RNA polymerase J. Virol. 85 2011 10364 10374
57. A.S. de Jong Determinants for membrane association and permeabilization of the coxsackievirus 2B protein and the identification of the Golgi complex as the target organelle J. Biol. Chem. 278 2003 1012 1021 (Pubitemid 36790779)
58. F.J. van Kuppeveld Homomultimerization of the coxsackievirus 2B protein in living cells visualized by fluorescence resonance energy transfer microscopy J. Virol. 76 2002 9446 9456 (Pubitemid 34919901)
59. L. Zemach The interaction of amiloride with acetylcholinesterase and butyrylcholinesterase FEBS Lett. 263 1990 166 168 (Pubitemid 20107804)
60. E. Zeslawska Crystals of the urokinase type plasminogen activator variant beta(c)-uPAin complex with small molecule inhibitors open the way towards structure-based drug design J. Mol. Biol. 301 2000 465 475